CytomX Therapeutics

CYTOMX THERAPEUTICS - Management Team and Key People

• • NAME
  • TITLE
  • BIO
• • Charles Homcy, MD, Chairman, Third Rock Ventures
  • Board of Directors
  • Charles Homcy joined Third Rock Ventures in 2010 as a Venture Partner. Charles co-founded Portola Pharmaceuticals in 2003, and served as President and Chief Executive Officer from that time until April 2010. Prior to that, he was President of Research and Development at Millennium following Millennium's acquisition of More>>
• • Fred Gluck
  • Board of Directors
  • Fred Gluck is a former managing partner (CEO) of McKinsey & Company, Inc., the international management consulting firm (1967-1995 More>>

• • Henry Lowman, PhD
  • VP of Research
  • Dr. Lowman earned a B. A. in chemistry at the Johns Hopkins University, and a Ph.D. in chemistry at Purdue University, before moving to Genentech, Inc., where he spent the next 20 years in research and development of protein and antibody therapeutics. His career there began as an NIH Postdoctoral Fellow in the lab of D More>>

• • James W. West, Ph.D.
  • Director of Research
  • Dr. West received a B.S. in Chemistry from the University of Missouri, an M.S. in Organic Chemistry from the University of Toledo, and a Ph.D. in Pharmacology from the University of Washington. As early as 1980 he used protein engineering to understand structural aspects of protein secretion, to develop molecular model More>>

• • View More
    Professionals >>